Benitec Biopharma Limited
BNTCW
BNTCW was delisted on the 14th of April, 2020.
2 hedge funds and large institutions have $2K invested in Benitec Biopharma Limited in 2019 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
83% less capital invested
Capital invested by funds: $12K → $2K (-$10K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$99 |
BNTCW Hedge Fund Activity: Q2 2019 in Review
2 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Benitec Biopharma Limited (BNTCW) for Q2 2019, worth a combined $2K — down 83% from $12K a quarter earlier.
Fund positioning in BNTCW was balanced in Q2 2019: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Sabby Management, cutting an estimated $99.
- 2 institutional investors held Benitec Biopharma Limited (BNTCW) as of Q2 2019, unchanged from Q1 2019.
- Funds reported $2K of Benitec Biopharma Limited stock for Q2 2019, down 83% quarter-over-quarter.
- 0 funds opened new Benitec Biopharma Limited positions in Q2 2019 and 0 closed out.
- The largest Benitec Biopharma Limited seller in Q2 2019 was Sabby Management, an estimated $99 sold.
Based on aggregated 13F filings for Q2 2019.